Fig. 3From: Leukadherin-1 ameliorates endothelial barrier damage mediated by neutrophils from critically ill patientsLA-1 inhibits neutrophil transendothelial migration. Neutrophils from healthy donors were activated by fMLP prior to addition onto endothelial monolayers grown on type I collagen as described in the “Methods” section. PMNs migrated across endothelial were counted, and data is shown as mean ± SEM, two-way ANOVA with post hoc Tukey analysis, *p < 0.05 LA-1 vs. untreated or DMSO-treated neutrophilsBack to article page